Claims records for 401,450 US women who began tamoxifen or an aromatase inhibitor after breast surgery were linked to commercial scores estimating attitudes and circumstances. Of these women, 69.9% had a medication possession ratio of 80% or more over the first 365 days. After adjustment for clinical and demographic factors, comfort following medication instructions and proximity to a breast oncologist carried adjusted odds ratios of 1.15 and 1.17.
Why it is interesting: A national first-year adherence figure for a therapy whose benefit depends on five to ten years of daily use.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.